MOSCOW, March 2. / TASS /. Former chief sanitary doctor of the Russian Federation, academician of the Russian Academy of Sciences, first deputy chairman of the State Duma Committee on Education and Science Gennady Onishchenko was skeptical about the fashion of choosing which drug to be vaccinated against coronavirus. According to him, all registered Russian vaccines are equal in effectiveness and safety.
"This newfangled tendency to choose a vaccine for itself, to collect data on it, on the one hand, of course, makes me happy, because people have finally begun to take an interest. But this is not the point - let's trust the doctors, let's go for vaccination, and there the doctor will decide whether you can get vaccinated today or not, "he said at a press conference on Tuesday.
According to Onishchenko, there is no need to choose a vaccine. "Come to the vaccination station, your doctor will prescribe the vaccine that you have. I can clearly and clearly say: we have three vaccines, they are approximately equal in safety and effectiveness, they are on the same scale," he added.
Onishchenko said that all vaccines already developed will work against the so-called British strain of coronavirus.
He also noted that it is incorrect to call this coronavirus subtype a British strain. “The new British strain of coronavirus is a misnomer. We have described the strains of the coronavirus, for this century, starting in 2002, we have three new strains - SARS, MERS and 'corona.' The natural focus has passed to the human population. As for this British virus, this is the same COVID-19, the same virus, the only thing that has mutated in it, "he said at a press conference on Tuesday.
According to Onishchenko, "a priori we can say that all those vaccines that were invented for the previous subtypes will work with this [British] strain." This is because, even after mutation, there is no "strong drift" in the structure of the virus.
"It is not typical for this type of viruses that they change like a flu strain," he stressed, noting that, for example, the H1N1 influenza virus is prone to sharp mutational "drifts" that make it easy to overcome the immune barrier.
A difficult epidemiological situation began to take shape in the UK since December last year due to the spread of a mutated strain of coronavirus, which, according to preliminary estimates of experts, can be up to 70% more infectious, and its mortality rate can be 30% higher. Since January 4, quarantine has been in effect throughout the country, which will begin to weaken from March 8.